Beta-L-D4A blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART). It targets HIV-1.
Molecular Weight
233.23
Molecular Formula
C10H11N5O2
Targets
HIV-1
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Beta-L-D4A is used to research its role as an HIV protease inhibitor, aimed at interrupting the HIV life cycle.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
